OSbiome has secured a lead investor and is looking to raise follow on funding. 

1 in 10 people in the world suffers from chronic gut issues, the majority of which are preventable with nutrition & lifestyle changes. Instead, consumers spend over  US$500 per month on fixes that are generic and temporary.

OSbiome provides users live visibility of their gut microbiome via home-based lab-grade gut microbiome sequencing and analysis. They provide bespoke, actionable steps for consumers to target their specific issues.

In 7 months, OSbiome’s launch kits sold out in 3 weeks, they’ve signed a distribution channel to access 5M end users, and they have developed a suite of proprietary tech, including a DNA pipeline outperforming external labs by 5X.